Stay updated on CBDV vs. Placebo in Children With ASD Clinical Trial
Sign up to get notified when there's something new on the CBDV vs. Placebo in Children With ASD Clinical Trial page.

Latest updates to the CBDV vs. Placebo in Children With ASD Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference1%
- Check12 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check48 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a trial studying the efficacy and safety of cannabidivarin (CBDV) in children with Autism Spectrum Disorder (ASD), while adding new details about the trial's design and collaborators.SummaryDifference43%
- Check56 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check99 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to CBDV vs. Placebo in Children With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CBDV vs. Placebo in Children With ASD Clinical Trial page.